Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

LUMIGAN

ALLERGAN INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is LUMIGAN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that LUMIGAN 0.03% has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength0.03%
Last updated2017-10-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

VISTITAN

SANDOZ CANADA INCORPORATED

0.03% · DIN 02429063

Same strengthSame dosage formSame routeNo current shortage

LUMIGAN PF

ALLERGAN INC

0.03% · DIN 02400162

Same strengthSame dosage formSame routeNo current shortage

JAMP BIMATOPROST

JAMP PHARMA CORPORATION

0.03% · DIN 02567385

Same strengthSame dosage formSame routeNo current shortage

ZIMED PF

LUVO MEDICAL TECHNOLOGIES INC

0.03% · DIN 02533464

Same strengthSame dosage formSame routeNo current shortage

Other Products

APO-BIMATOPROST

APOTEX INC

0.03% · DIN 02402505

Same strengthSame dosage formDifferent routeNo current shortage

LATISSE

ABBVIE CORPORATION

0.03% · DIN 02350939

Same strengthSame dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02245860

Strength

0.03%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

BIMATOPROST

See all BIMATOPROST products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History